Prevalence of SARS-CoV-2 infection in patients presenting for intravitreal injection.
Stephan SzegediWolfgang HufKata MiháltzPia Veronika Vécsei-MarlovitsPublished in: Spektrum der Augenheilkunde : Zeitschrift der Osterreichischen Ophthalmologischen Gesellschaft, OOG (2020)
The study provides an estimate for the prevalence of SARS-CoV‑2 infection in asymptomatic patients presenting for IVI. While these data may be used as a baseline, further research is needed to assess the development of SARS-CoV‑2 prevalence in this patient group in order to support risk assessment and infection prevention strategies.
Keyphrases